HPSI0516i-kumr_11

General

Cell Line

hPSCreg name WTSIi709-A
Cite as:
WTSIi709-A (RRID:CVCL_LL52)
Alternative name(s)
HPSI0516i-kumr_11
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
WTSIi697-B
(HPSI0516i-dewa_5)
Donor diseases:
obsolete CLN3 disease
WTSIi641-B
(HPSI0516i-aaun_5)
Donor diseases:
obsolete CLN3 disease
WTSIi672-B
(HPSI0516i-quqp_4)
Donor diseases:
obsolete CLN3 disease
WTSIi697-A
(HPSI0516i-dewa_2)
Donor diseases:
obsolete CLN3 disease
WTSIi672-A
(HPSI0516i-quqp_6)
Donor diseases:
obsolete CLN3 disease
WTSIi641-A
(HPSI0516i-aaun_6)
Donor diseases:
obsolete CLN3 disease
WTSIi563-A
(HPSI0516i-zujs_5)
Donor diseases:
obsolete CLN3 disease
WTSIi480-B
(HPSI0516i-iuoc_2)
Donor diseases:
obsolete CLN3 disease
WTSIi662-A
(HPSI1116i-mebq_1)
Donor diseases:
obsolete CLN3 disease
WTSIi480-A
(HPSI0516i-iuoc_5)
Donor diseases:
obsolete CLN3 disease
WTSIi662-B
(HPSI1116i-mebq_7)
Donor diseases:
obsolete CLN3 disease
WTSIi622-A
(HPSI0516i-menz_4)
Donor diseases:
obsolete CLN3 disease
WTSIi496-A
(HPSI0516i-yibc_4)
Donor diseases:
obsolete CLN3 disease
WTSIi622-B
(HPSI0516i-menz_3)
Donor diseases:
obsolete CLN3 disease
Last update 22nd May 2019
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Wellcome Sanger Institute (WTSI)
Distributors

External Databases

HipSci HPSI0516i-kumr_11
BioSamples SAMEA104012236
Cellosaurus CVCL_LL52
Wikidata Q54890967

General Information

Projects
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex female
Age of donor (at collection) 15-19
Ethnicity Portuguese

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.

External Databases (Donor)

BioSamples SAMEA4454004

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Please provide contact information of the holder of the original Donor Information Sheet.
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? No
Please provide the contact information
Alternatives to consent
Alternative consent approval number
Is there other documentation provided to the donor for consenting purposes? No
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Details on restriction to research project
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed?
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Please describe how access is provided:
Contact data, institution, or website:
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? No
Name of accrediting authority involved?
Approval number
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Hampstead Research Ethics Committee
Approval number 13/LO/0171
Please describe:
Further constraints on use
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
Constraints for use or distribution

hIPSC Derivation

General

Source cell type
A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.; These cells may be vimentin-positive, fibronectin-positive, fsp1-positive, MMP-1-positive, collagen I-positive, collagen III-positive, and alpha-SMA-negative.
Source cell origin
Any portion of the organ that covers that body and consists of a layer of epidermis and a layer of dermis.
Synonyms
  • portion of skin
  • region of skin
  • skin
  • skin region
  • skin zone
show more synonyms
Age of donor (at collection) 15-19
Collected in 2016
Source cell line vendor University College London

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Notes on reprogramming vector detection CytoTune 2

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Surface coating Vitronectin
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
CO2 Concentration 5 %
Medium TeSR™ E8™

Characterisation

Analysis of Undifferentiated Cells
Pluripotency Score Novelty Score
35.584 1.342

Certificate of Analysis

Is there a certificate of analysis available?
Yes
Passage:

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
No

Other Genotyping (Cell Line)

Is there genome-wide genotyping or functional data available?
Yes